Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical Outcomes
medRxiv Preprint Server – January 30, 2024
Source: medRxiv
Summary
Many struggling with depression and anxiety found significant relief. A treatment involving repeated at-home sublingual ketamine was explored for these conditions. It showed notable symptom reduction and a favorable safety profile, with minimal adverse effects and no long-term use concerns. This suggests a promising, well-tolerated mental health option.
Abstract
Objective To evaluate the effectiveness of repeated at-home ketamine treatments for depression, generalized anxiety, and social anxiety and assess safety in terms of adverse effects and tendency towards long-term use.